BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30037446)

  • 1. Rapid Fire: Acute Blast Crisis/Hyperviscosity Syndrome.
    Emerson G; Kaide CG
    Emerg Med Clin North Am; 2018 Aug; 36(3):603-608. PubMed ID: 30037446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
    Korkmaz S
    Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperleukocytosis and leukostasis in acute and chronic leukemias.
    Macaron W; Sargsyan Z; Short NJ
    Leuk Lymphoma; 2022 Aug; 63(8):1780-1791. PubMed ID: 35357988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
    Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
    Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
    Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
    Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
    Shafique S; Bona R; Kaplan AA
    Ther Apher Dial; 2007 Apr; 11(2):146-9. PubMed ID: 17381536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis.
    Pham HP; Schwartz J
    Transfusion; 2015 Oct; 55(10):2306-11; quiz 2305. PubMed ID: 26267387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
    Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
    Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre.
    Sil S; Mohan AK; Negi G; Banerjee P; Kaur D; Mittal A; Jain A
    Transfus Clin Biol; 2024 Feb; 31(1):36-40. PubMed ID: 37944664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia.
    Aqui N; O'Doherty U
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):457-60. PubMed ID: 25696894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
    Tan D; Hwang W; Goh YT
    Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytoreduction for acute leukemia.
    Porcu P; Farag S; Marcucci G; Cataland SR; Kennedy MS; Bissell M
    Ther Apher; 2002 Feb; 6(1):15-23. PubMed ID: 11886572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
    Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
    Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukostasis: Management to Prevent Crisis in Acute Leukemia
.
    Blackburn LM; Brown S; Munyon A; Orovets M
    Clin J Oncol Nurs; 2017 Dec; 21(6):E267-E271. PubMed ID: 29149122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
    Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
    Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis.
    Göçer M; Kurtoğlu E
    Ther Apher Dial; 2021 Oct; 25(5):697-703. PubMed ID: 33686785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
    Bewersdorf JP; Zeidan AM
    Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
    Cline A; Jajosky R; Shikle J; Bollag R
    J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukostasis in Chronic Lymphocytic Leukemia.
    Singh N; Singh Lubana S; Dabrowski L; Sidhu G
    Am J Case Rep; 2020 Jul; 21():e924798. PubMed ID: 32616708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.